[1] |
Divakaran, S.; Loscalzo, J. The role of nitroglycerin and other nitrogen oxides in cardiovascular therapeutics. J. Am. Coll. Cardiol. 2017, 70, 2393–2410.
|
[2] |
Münzel, T.; Daiber, A.; Gori, T. More answers to the still unresolved question of nitrate tolerance. Eur. Heart. J. 2013, 34, 2666–2673.
|
[3] |
Daiber, A.; Münzel, T. Organic nitrate therapy, nitrate tolerance, and nitrate-induced endothelial dysfunction: emphasis on redox biology and oxidative stress. Antioxid. Redox. Signal. 2015, 23, 899–942.
|
[4] |
Münzel, T.; Steven, S.; Daiber, A. Organic nitrates: Update on mechanisms underlying vasodilation, tolerance and endothelial dysfunction. Vasc. Pharmacol. 2014, 63, 105–113.
|
[5] |
Münzel, T.; Daiber, A.; Gori, T. Nitrate therapy: new aspects concerning molecular action and tolerance. Circulation. 2011, 123, 2132–2144.
|
[6] |
Bai, Y.P.; Zhang, J.X.; Sun, Q.; Zhou, J.P.; Luo, J.M.; He, L.F.; Lin, X.C.; Zhu, L.P.; Wu, W.Z.; Wang, Z.Y.; Zhang, G.G. Induction of microRNA-199 by nitric oxide in endothelial cells is required for nitrovasodilator resistance via targeting of prostaglandin I2 synthase. Circulation. 2018, 138, 397–411.
|
[7] |
Kopp, F.; Mendell, J.T. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018, 172, 393–407.
|
[8] |
Boulberdaa, M.; Scott, E.; Ballantyne, M.; Garcia, R.; Descamps, B.; Angelini, G.D.; Brittan, M.; Hunter, A.; McBride, M.; McClure, J.; Miano, J.M.; Emanueli, C.; Mills, N.L.; Mountford, J.C.; Baker, A.H. A role for the long noncoding RNA SENCR in commitment and function of endothelial cells. Mol. Ther. 2016, 24, 978–990.
|
[9] |
Bell, R.D.; Long, X.C.; Lin, M.Y.; Bergmann, J.H.; Nanda, V.; Cowan, S.L.; Zhou, Q.; Han, Y.; Spector, D.L.; Zheng, D.Y.; Miano, J.M. Identification and initial functional characterization of a human vascular cell-enriched long noncoding RNA. Arterioscler. Thromb. Vasc. Biol. 2014, 34, 1249–1259.
|
[10] |
Zou, Z.Q.; Xu, J.; Li, L.; Han, Y.S. Down-regulation of SENCR promotes smooth muscle cells proliferation and migration in db/db mice through up-regulation of FoxO1 and TRPC6. Biomed. Pharmacother. 2015, 74, 35–41.
|
[11] |
Wu, G.Z.; Cai, J.; Han, Y.; Chen, J.H.; Huang, Z.P.; Chen, C.Y.; Cai, Y.; Huang, H.F.; Yang, Y.J.; Liu, Y.K.; Xu, Z.C.; He, D.F.; Zhang, X.Q.; Hu, X.Y.; Pinello, L.; Zhong, D.; He, F.T.; Yuan, G.C.; Wang, D.Z.; Zeng, C.Y. LincRNA-p21 regulates neointima formation, vascular smooth muscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity. Circulation. 2014, 130, 1452–1465.
|
[12] |
Zhao, J.J.; Zhang, W.; Lin, M.Y.; Wu, W.; Jiang, P.T.; Tou, E.; Xue, M.; Richards, A.; Jourd'Heuil, D.; Asif, A.; Zheng, D.Y.; Singer, H.A.; Miano, J.M.; Long, X.C. MYOSLID is a novel serum response factor-dependent long noncoding RNA that amplifies the vascular smooth muscle differentiation program. Arterioscler. Thromb. Vasc. Biol. 2016, 36, 2088–2099.
|
[13] |
Mahmoud, A.D.; Ballantyne, M.D.; Miscianinov, V.; Pinel, K.; Hung, J.; Scanlon, J.P.; Iyinikkel, J.; Kaczynski, J.; Tavares, A.S.; Bradshaw, A.C.; Mills, N.L.; Newby, D.E.; Caporali, A.; Gould, G.W.; George, S.J.; Ulitsky, I.; Sluimer, J.C.; Rodor, J.; Baker, A.H. The human-specific and smooth muscle cell-enriched LncRNA SMILR promotes proliferation by regulating mitotic CENPF mRNA and drives cell-cycle progression which can be targeted to limit vascular remodeling. Circ. Res. 2019, 125, 535–551.
|
[14] |
Li, F.P.; Lin, D.Q.; Gao, L.Y. LncRNA TUG1 promotes proliferation of vascular smooth muscle cell and atherosclerosis through regulating miRNA-21/PTEN axis. Eur. Rev. Med. Pharmacol. Sci. 2018, 22, 7439–7447.
|
[15] |
Csont, T.; Murlasits, Z.; Ménesi, D.; Kelemen, J.Z.; Bencsik, P.; Pipicz, M.; Fekete, V.; Zvara, Á.; Puskás, L.G.; Ferdinandy, P. Tissue-specific gene expression in rat hearts and aortas in a model of vascular nitrate tolerance. J. Cardiovasc. Pharmacol. 2015, 65, 485–493.
|
[16] |
Fekete, V.; Murlasits, Z.; Aypar, E.; Bencsik, P.; Sárközy, M.; Szénási, G.; Ferdinandy, P.; Csont, T. Myocardial postconditioning is lost in vascular nitrate tolerance. J. Cardiovasc. Pharmacol. 2013, 62, 298–303.
|
[17] |
Ferdinandy, P.; Szilvássy, Z.; Csont, T.; Csonka, C.; Nagy, E.; Koltai, M.; Dux, L. Nitroglycerin-induced direct protection of the ischaemic myocardium in isolated working hearts of rats with vascular tolerance to nitroglycerin. Br. J. Pharmacol. 1995, 115, 1129–1131.
|
[18] |
Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. Embnet. J. 2011, 17, 10.
|
[19] |
Langmead, B.; Salzberg, S.L. Fast gapped-read alignment with Bowtie 2. Nat. Methods. 2012, 9, 357–359.
|
[20] |
Kim, D.; Pertea, G.; Trapnell, C.; Pimentel, H.; Kelley, R.; Salzberg, S.L. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 2013, 14, R36.
|
[21] |
Pertea, M.; Pertea, G.M.; Antonescu, C.M.; Chang, T.C.; Mendell, J.T.; Salzberg, S.L. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat. Biotechnol. 2015, 33, 290–295.
|
[22] |
Frazee, A.C.; Pertea, G.; Jaffe, A.E.; Langmead, B.; Salzberg, S.L.; Leek, J.T. Ballgown bridges the gap between transcriptome assembly and expression analysis. Nat. Biotechnol. 2015, 33, 243–246.
|
[23] |
Kong, L.; Zhang, Y.; Ye, Z.Q.; Liu, X.Q.; Zhao, S.Q.; Wei, L.P.; Gao, G. CPC: assess the protein-coding potential of transcripts using sequence features and support vector machine. Nucleic Acids Res. 2007, 35, W345–W349.
|
[24] |
Sun, L.; Luo, H.T.; Bu, D.C.; Zhao, G.G.; Yu, K.T.; Zhang, C.H.; Liu, Y.N.; Chen, R.S.; Zhao, Y. Utilizing sequence intrinsic composition to classify protein-coding and long non-coding transcripts. Nucleic Acids Res. 2013, 41, e166.
|
[25] |
Trapnell, C.; Williams, B.A.; Pertea, G.; Mortazavi, A.; Kwan, G.; van Baren, M.J.; Salzberg, S.L.; Wold, B.J.; Pachter, L. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 2010, 28, 511–515.
|
[26] |
Krämer, A.; Green, J.; Pollard, J.; Tugendreich, S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics. 2014, 30, 523–530.
|
[27] |
Colussi, C.; Scopece, A.; Vitale, S.; Spallotta, F.; Mattiussi, S.; Rosati, J.; Illi, B.; Mai, A.; Castellano, S.; Sbardella, G.; Farsetti, A.; Capogrossi, M.C.; Gaetano, C. P300/CBP associated factor regulates nitroglycerin-dependent arterial relaxation by Nε-lysine acetylation of contractile proteins. Arterioscler. Thromb. Vasc. Biol. 2012, 32, 2435–2443.
|
[28] |
Zhu, L.W.; Li, N.; Sun, L.B.; Zheng, D.W.; Shao, G.F. Non-coding RNAs: The key detectors and regulators in cardiovascular disease. Genomics. 2021, 113, 1233–1246.
|
[29] |
Yang, Q.; Li, D.; Feng, C.; Fan, Y.; Li, H.; Du, Q. Genome-wide identification of long noncoding RNAs in myocyte differentiation. J. Chin. Pharm. Sci. 2017, 26, 423–431.
|
[30] |
Wang, E.Q.; Lee, W.I.; Brazeau, D.; Fung, H.L. cDNA Microarray analysis of vascular gene expression after nitric oxide donor infusion in rats: Implications for nitrate tolerance mechanisms. AAPS PharmSci. 2002, 4, 45–55.
|
[31] |
Kashyap, S.; Osman, M.; Ferguson, C.M.; Nath, M.C.; Roy, B.; Lien, K.R.; Nath, K.A.; Garovic, V.D.; Lerman, L.O.; Grande, J.P. Ccl2 deficiency protects against chronic renal injury in murine renovascular hypertension. Sci. Rep. 2018, 8, 8598.
|
[32] |
Tellides, G.; Pober, J.S. Inflammatory and immune responses in the arterial media. Circ. Res. 2015, 116, 312–322.
|
[33] |
Maruyama, K.; Kagota, S.; McGuire, J.J.; Wakuda, H.; Yoshikawa, N.; Nakamura, K.; Shinozuka, K. Enhanced nitric oxide synthase activation via protease-activated receptor 2 is involved in the preserved vasodilation in aortas from metabolic syndrome rats. J. Vasc. Res. 2015, 52, 232–243.
|
[34] |
Hughes, K.H.; Wijekoon, E.P.; Valcour, J.E.; Chia, E.W.; McGuire, J.J. Effects of chronic in-vivo treatments with protease-activated receptor 2 agonist on endothelium function and blood pressures in mice. Can. J. Physiol. Pharmacol. 2013, 91, 295–305.
|
[35] |
McGuire, J.J.; van Vliet, B.N.; Giménez, J.; King, J.C.; Halfyard, S.J. Persistence of PAR-2 vasodilation despite endothelial dysfunction in BPH/2 hypertensive mice. Pflugers Arch. 2007, 454, 535–543.
|
[36] |
Wu, J.P.; Yan, N.E.; Yan, Z. Structure-Function Relationship of the Voltage-Gated Calcium Channel Cav1.1 Complex. Membr. Dyn. Calcium Signal. 2017, 981, 23–39.
|
[37] |
Petkov, G.V. Central role of the BK channel in urinary bladder smooth muscle physiology and pathophysiology. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2014, 307, R571–R584.
|
[38] |
Köhler, R.; Kaistha, B.P.; Wulff, H. Vascular KCa-channels as therapeutic targets in hypertension and restenosis disease. Expert. Opin. Ther. Targets. 2010, 14, 143–155.
|
[39] |
Tanaka, Y.; Koike, K.; Toro, L. MaxiK channel roles in blood vessel relaxations induced by endothelium-derived relaxing factors and their molecular mechanisms. J. Smooth Muscle Res. 2004, 40, 125–153.
|
[40] |
Matsumoto, A.; Pasut, A.; Matsumoto, M.; Yamashita, R.; Fung, J.; Monteleone, E.; Saghatelian, A.; Nakayama, K.I.; Clohessy, J.G.; Pandolfi, P.P. mTORC1 and muscle regeneration are regulated by the LINC00961-encoded SPAR polypeptide. Nature. 2017, 541, 228–232.
|